Understanding attitudes and obstacles to vaccination against COVID-19 in patients with primary immunodeficiency

Abstract Background Patients with primary immunodeficiency (PID) are at increased risk for infections such as SARS-CoV-2 (COVID-19), due to the nature of their diseases and being immunocompromised. At this time, four vaccines against COVID-19 (Pfizer-BioNtech’s Comirnaty®, Moderna’s Spikevax®, Astra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Babak Aberumand, Whitney Ayoub Goulstone, Stephen Betschel
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-05-01
Colecção:Allergy, Asthma & Clinical Immunology
Assuntos:
COVID-19
SARS-CoV-2
Immune response
Immunocompromised
Immunosuppressed
Primary immunodeficiency
Acesso em linha:https://doi.org/10.1186/s13223-022-00679-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados